Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $16.5M | 12 | 90.3% |
| Acquisitions | $1.8M | 6 | 9.7% |
| Food and Beverage | $920.19 | 26 | 0.0% |
| Travel and Lodging | $695.83 | 6 | 0.0% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic MiniMed, Inc. | $14.7M | 4 | $0 (2020) |
| Medtronic, Inc. | $1.8M | 6 | $0 (2024) |
| Medtronic Vascular, Inc. | $1.4M | 7 | $0 (2019) |
| Medtronic USA, Inc. | $447,206 | 1 | $0 (2019) |
| Zimmer Biomet Holdings, Inc. | $1,181 | 9 | $0 (2024) |
| Flexion Therapeutics, Inc. | $164.48 | 11 | $0 (2020) |
| Sonex Health, Inc. | $56.57 | 2 | $0 (2021) |
| Pacira Pharmaceuticals Incorporated | $54.05 | 2 | $0 (2024) |
| Pacira Therapeutics, Inc. | $48.76 | 3 | $0 (2021) |
| Ethicon US, LLC | $33.52 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $611,360 | 7 | Medtronic, Inc. ($610,829) |
| 2022 | $0 | 1 | BlackSwan Vascular, Inc. |
| 2021 | $1.2M | 9 | Medtronic, Inc. ($1.2M) |
| 2020 | $14.7M | 8 | Medtronic MiniMed, Inc. ($14.7M) |
| 2019 | $1.3M | 13 | Medtronic Vascular, Inc. ($879,024) |
| 2018 | $487,021 | 14 | Medtronic Vascular, Inc. ($486,850) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 09/05/2024 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Acquisitions | Cash or cash equivalent | $387,769.22 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 09/05/2024 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Acquisitions | Cash or cash equivalent | $223,060.12 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 07/16/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Pain Management | ||||||
| 06/19/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: Wound Closure | ||||||
| 06/12/2024 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $420.88 | General |
| Category: Knees | ||||||
| 05/14/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Pain Management | ||||||
| 2022 | BlackSwan Vascular, Inc. | — | — | — | $0.00 | Ownership |
| 12/20/2021 | Medtronic, Inc. | InPen (Device) | Acquisitions | Cash or cash equivalent | $401,436.06 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 12/20/2021 | Medtronic, Inc. | InPen (Device) | Acquisitions | Cash or cash equivalent | $230,921.81 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 08/26/2021 | Pacira Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Musculoskeletal | ||||||
| 07/15/2021 | Pacira Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Musculoskeletal | ||||||
| 06/02/2021 | Pacira Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Musculoskeletal | ||||||
| 01/29/2021 | Medtronic, Inc. | — | Acquisitions | Cash or cash equivalent | $429,318.00 | General |
| 01/29/2021 | Medtronic, Inc. | — | Acquisitions | Cash or cash equivalent | $92,825.51 | General |
| 01/14/2021 | Sonex Health, Inc. | ULTRAGUIDECTR (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ORTHOPEDIC | ||||||
| 2021 | BlackSwan Vascular, Inc. | — | — | — | $0.00 | Ownership |
| 12/10/2020 | Medtronic MiniMed, Inc. | InPen (Device) | Royalty or License | Cash or cash equivalent | $1,772,393.80 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 12/10/2020 | Medtronic MiniMed, Inc. | InPen (Device) | Royalty or License | Cash or cash equivalent | $1,019,550.60 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 10/21/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Musculoskeletal | ||||||
| 09/10/2020 | Medtronic MiniMed, Inc. | InPen (Device) | Royalty or License | Cash or cash equivalent | $7,563,587.00 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 09/10/2020 | Medtronic MiniMed, Inc. | InPen (Device) | Royalty or License | Cash or cash equivalent | $4,350,873.00 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 07/07/2020 | Sonex Health, Inc. | Sx-one Microknife (Device) | Food and Beverage | In-kind items and services | $39.57 | General |
| Category: Orthopedic | ||||||
| 05/12/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Musculoskeletal | ||||||
| 01/29/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Musculoskeletal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 499 | 1,825 | $449,674 | $95,516 |
| 2022 | 11 | 553 | 2,074 | $438,905 | $118,581 |
| 2021 | 13 | 728 | 2,718 | $540,770 | $152,937 |
| 2020 | 12 | 762 | 1,938 | $473,551 | $123,759 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2023 | 28 | 28 | $154,027 | $20,799 | 13.5% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 18 | 1,024 | $24,576 | $13,650 | 55.5% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 25 | 33 | $41,184 | $13,133 | 31.9% |
| 27245 | Treatment of broken neck of thigh bone with bone implant | Facility | 2023 | 12 | 12 | $67,464 | $11,718 | 17.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 167 | 247 | $22,549 | $10,080 | 44.7% |
| 27130 | Replacement of thigh bone and hip joint with prosthesis | Facility | 2023 | 14 | 14 | $86,582 | $9,857 | 11.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $15,100 | $6,795 | 45.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 65 | 89 | $23,552 | $4,939 | 21.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 39 | $11,911 | $3,829 | 32.1% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 11 | 12 | $2,096 | $518.54 | 24.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 46 | 251 | $632.50 | $198.05 | 31.3% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2022 | 34 | 46 | $61,152 | $33,695 | 55.1% |
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2022 | 21 | 21 | $131,699 | $18,207 | 13.8% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2022 | 22 | 1,218 | $30,768 | $16,331 | 53.1% |
| 27245 | Treatment of broken neck of thigh bone with bone implant | Facility | 2022 | 14 | 14 | $78,708 | $13,873 | 17.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 162 | 237 | $20,230 | $10,414 | 51.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 109 | 109 | $21,037 | $9,113 | 43.3% |
| 27130 | Replacement of thigh bone and hip joint with prosthesis | Facility | 2022 | 13 | 13 | $62,083 | $6,487 | 10.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 78 | 106 | $20,884 | $5,397 | 25.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 34 | $9,826 | $3,683 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $1,815 | $1,161 | 64.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 55 | 265 | $702.50 | $220.89 | 31.4% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2021 | 25 | 39 | $46,553 | $36,094 | 77.5% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2021 | 35 | 1,614 | $39,288 | $22,966 | 58.5% |
| 27447 | Repair of knee joint, lower or upper part of joint, inside and outside area | Facility | 2021 | 23 | 25 | $125,968 | $17,510 | 13.9% |
About Dr. Marshall Ching, M.D
Dr. Marshall Ching, M.D is a Specialist healthcare provider based in Oroville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215036835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marshall Ching, M.D has received a total of $18.3M in payments from pharmaceutical and medical device companies, with $611,360 received in 2024. These payments were reported across 52 transactions from 15 companies. The most common payment nature is "Royalty or License" ($16.5M).
As a Medicare-enrolled provider, Ching has provided services to 2,542 Medicare beneficiaries, totaling 8,555 services with total Medicare billing of $490,794. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Oroville, CA
- Active Since 09/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215036835
Products in Payments
- InPen (Device) $15.3M
- VenaSeal (Device) $1.4M
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $610,829
- ROSA (Device) $1,144
- Zilretta (Drug) $213.24
- Exparel (Drug) $54.05
- Sx-one Microknife (Device) $39.57
- VISCO-3 (Biological) $36.96
- STRATAFIX (Device) $33.52
- ZYNRELEF (Drug) $22.70
- Neuromodulation Dspsbls and Accs (Device) $17.68
- ULTRAGUIDECTR (Device) $17.00
- OFIRMEV (Drug) $15.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Oroville
Dr. Brian Ching, M.d, M.D
Specialist — Payments: $1.5M
Dr. Love Dalal, M.d, M.D
Specialist — Payments: $3,038
Dr. Lowell Nickel, M.d, M.D
Specialist
Dr. Dominique Engel, M.d, M.D
Specialist
Celeste Valladarez, Cmt, CMT
Specialist
Steven Daniels, Cp, CP
Specialist